Home » Stocks » Vitality Biopharma

Vitality Biopharma Inc. (VBIO)

Stock Price: $0.195 USD 0.065 (50.00%)
Updated Aug 10, 2020 4:00 PM EDT - End of day

Stock Price Chart

Key Info

Market Cap 9.91M
Revenue (ttm) 258,288
Net Income (ttm) -4.37M
Shares Out 50.84M
EPS (ttm) -0.09
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 10, 2020
Last Price $0.195
Previous Close $0.130
Change ($) 0.065
Change (%) 50.00%
Day's Open 0.250
Day's Range 0.141 - 0.250
Day's Volume 31,326
52-Week Range 0.005 - 0.250

More Stats

Market Cap 9.91M
Enterprise Value 7.61M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 50.84M
Float 34.12M
EPS (basic) -0.08
EPS (diluted) -0.09
FCF / Share -0.07
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta 3.54
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 38.38
PB Ratio 7.14
Revenue 258,288
Operating Income -3.69M
Net Income -4.37M
Free Cash Flow -3.59M
Net Cash 2.30M
Net Cash / Share 0.05
Gross Margin -76.07%
Operating Margin -1,429.69%
Profit Margin n/a
FCF Margin -1,390.12%
ROA -53.41%
ROE -115.25%
ROIC 438.70%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

Current: $0.195
Target: 10.40
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth---37.31%-34.22%1.09%----
Gross Profit--
Operating Income-3.69-4.57-4.40-3.47-2.74-3.81-3.60-2.55-1.30
Net Income-4.37-13.12-4.31-5.22-0.14-4.05-4.15-2.74-1.32
Shares Outstanding51.5433.0023.1213.597.547.046.015.345.15
Earnings Per Share-0.08-0.61-0.19-0.38-0.02-0.60-0.70-0.50-0.30
Operating Cash Flow-3.59-3.67-2.89-1.38-1.69-2.50-2.13-1.65-0.24
Free Cash Flow-3.59-3.67-2.89-1.38-1.69-2.50-2.13-1.65-0.24
Cash & Equivalents2.436.010.661.150.100.391.400.390.53
Total Debt0.13------0.580.47
Net Cash / Debt2.306.010.661.150.100.391.40-0.190.06
Book Value1.285.020.320.37-0.52-1.08-0.11-0.57-0.05
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Vitality Biopharma Inc.
Country United States
Employees 5
CEO Michael Cavanaugh

Stock Information

Ticker Symbol VBIO
Stock Exchange US OTC
Sector Healthcare
Industry Biotechnology
Unique Identifier OTCMKTS: VBIO


Vitality Biopharma, Inc. engages in the development of cannabinoid pharmaceuticals for the treatment of inflammatory disorders in the United States. The company is developing tetrahydrocannabinol glycoside (VBX-100), an oral cannabinoid prodrug for inflammatory bowel disease and irritable bowel syndromes. The company was formerly known as Stevia First Corp. and changed its name to Vitality Biopharma, Inc. in July 2016. Vitality Biopharma, Inc. was founded in 2007 and is headquartered in Los Angeles, California.